MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/ijgo.70750

Медицинская библиотека · International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025

Post protocol residual thickness as a negative predictor for pharmacological treatment in early pregnancy loss.

Pertez-Machluf Ravit, Kimhi Maya, Yedidia Moser Rotem, Rosen David, Daykan Yair, Schonman Ron, Klein Zvi, Yagur Yael

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

To determine the rate of pharmacological treatment failure in early pregnancy loss, assess post-treatment residua thickness as a predictor of retained products of conception (RPOC), identify a clinically relevant cutoff, and evaluate additional clinical and sonographic predictors.

METHODS

This retrospective cohort study was conducted at a tertiary medical center and included patients treated with mifepristone-misoprostol for first-trimester pregnancy loss between January 2019 and January 2022. Treatment success was assessed via transvaginal ultrasound, with residua thickness measured 14 days post-treatment. The primary outcome was failure, defined as histologically confirmed RPOC following hysteroscopy. Secondary analyses evaluated clinical and sonographic predictors, focusing on post-treatment residual thickness. Statistical analysis included receiver operating characteristic (ROC) curve assessment and multivariable logistic regression.

RESULTS

Of the 717 patients included, 537 (74.9%) achieved successful medical management without further intervention, while 180 (25.1%) required intervention. Treatment failure was associated with greater post-treatment residua thickness (mean 19.1 ± 9.1 mm vs. 10.4 ± 6.7 mm, P < 0.001). Residua thickness was an independent predictor of failure (adjusted odds ratio [aOR] 1.17, 95% confidence interval [CI]: 1.13-1.21, P < 0.001). ROC analysis identified an optimal cutoff of 14.9 mm, yielding 70% sensitivity and 81% specificity (area under the curve [AUC]: 0.835, 95% CI: 0.80-0.87) for predicting the need for surgical intervention.

CONCLUSION

Post-treatment residual thickness is a significant predictor of pharmacological treatment failure in early pregnancy loss, with a clinically relevant cutoff of approximately 15 mm. Histologic validation provides a promising framework for refining management protocols, emphasizing the need for further studies to establish robust predictive criteria.

Для цитирования: Pertez-Machluf Ravit, Kimhi Maya, Yedidia Moser Rotem, Rosen David, Daykan Yair, Schonman Ron, Klein Zvi, Yagur Yael. Post protocol residual thickness as a negative predictor for pharmacological treatment in early pregnancy loss.. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2025. DOI: 10.1002/ijgo.70750.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.